Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Study of Anti-Inflammatory Activity of a New Non-Opioid Analgesic on the Basis of a Selective Inhibitor of TRPA1 ion Channels.

Beskhmelnitsyna EA, Pokrovskii MV, Kulikov AL, Peresypkina AA, Varavin EI.

Antiinflamm Antiallergy Agents Med Chem. 2019 Feb 8. doi: 10.2174/1871523018666190208123700. [Epub ahead of print]

PMID:
30734687
2.

Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974.

Pokrovskii MV, Korokin MV, Kudryavtsev KV, Pokrovskaya TG, Gudyrev OS, Gureev VV, Korokina LV, Povetkin SV.

Bull Exp Biol Med. 2017 Aug;163(4):436-438. doi: 10.1007/s10517-017-3822-y. Epub 2017 Aug 29.

PMID:
28853095
3.

A small-molecule inhibitor of hepatitis C virus infectivity.

Bush CO, Pokrovskii MV, Saito R, Morganelli P, Canales E, Clarke MO, Lazerwith SE, Golde J, Reid BG, Babaoglu K, Pagratis N, Zhong W, Delaney WE 4th, Paulson MS, Beran RK.

Antimicrob Agents Chemother. 2014;58(1):386-96. doi: 10.1128/AAC.02083-13. Epub 2013 Oct 28.

4.

[Comparative evaluation of the osteoprotective effects of resveratrol and resveratrol/enalapril combination in the treatment of experimental osteoporosis].

Faĭtel'son AV, Koklina NIu, Gudyrev OS, Dubrovin GM, Pokrovskiĭ MV, Ivanov AV.

Eksp Klin Farmakol. 2012;75(5):35-8. Russian.

PMID:
22834128
5.

[Correction of endothelial dysfunction by L-arginine under experimental pre-eclampsia conditions].

Pokrovskiĭ MV, Pokrovskaia TG, Gureev VV, Barsuk AA, Proskuriakova EV, Korokin MV, Gudyrev OS, Belous AS, Kochkarov VI, Danilenko LM, Levashova OV, Mal'tseva NV, Polianskaia OS.

Eksp Klin Farmakol. 2012;75(2):14-6. Russian.

PMID:
22550853
6.

An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture.

Chan K, Cheng G, Beran RK, Yang H, Appleby TC, Pokrovskii MV, Mo H, Zhong W, Delaney WE 4th.

Virology. 2012 Jan 20;422(2):224-34. doi: 10.1016/j.virol.2011.10.022. Epub 2011 Nov 17.

7.

Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, Tirunagari N, Fenaux M, Greenstein AE, Zhong W, Delaney WE 4th, Paulson MS.

J Virol. 2011 Apr;85(8):3978-85. doi: 10.1128/JVI.01760-10. Epub 2011 Feb 2.

8.

[Integrated assessment of endothelio- and cardioprotective activity of macrolide antibiotics in nitric oxide deficiency model].

Chernomortseva ES, Pokrovskiĭ MV, Titareva LV, Pokrovskaia TG, Gureev VV.

Eksp Klin Farmakol. 2010 Sep;73(9):20-3. Russian.

PMID:
21086648
9.

Comparative study of potential endothelioprotectors and impaza in modeled nitric oxide deficiency.

Pokrovskii MV, Kochkarov VI, Pokrovskaya TG, Artyushkova EB, Pashin EN, Danilenko LM, Korokin MV, Belous AS, Korokina LV, Malykhin VA, Zaloznykh YI, Brusnik MS, Zhavbert ES.

Bull Exp Biol Med. 2009 Sep;148(3):514-7. English, Russian.

PMID:
20396727
10.

Correction of endothelial dysfunction with impaza preparation in complex with enalapril and losartan during modeling of NO deficiency.

Belous AS, Pokrovskii MV, Pokrovskaya TG, Kochkarov VI, Artyushkova EB, Pashin EN, Zhavbert ES.

Bull Exp Biol Med. 2009 Sep;148(3):511-3. English, Russian.

PMID:
20396726
11.

[Experimental study of cardioprotective and endothelioprotective action of macrolides and azalides].

Chernomortseva ES, Pokrovskiĭ MV, Pokrovskaia TG, Artiushkova EB, Gureev VV.

Eksp Klin Farmakol. 2009 Mar-Apr;72(2):29-31. Russian.

PMID:
19441724
12.

[Pharmacological correction of experimental chronic limb ischemia].

Artiushkova EB, Pashkov DV, Pokrovskiĭ MV, Faĭtel'son AV, Gudyrev OS, Pokrovskaia TG, Pashin EN, Kochkarov VI.

Eksp Klin Farmakol. 2008 May-Jun;71(3):23-5. Russian.

PMID:
18652251
13.

[Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].

Pokrovskiĭ MV, Pokrovskaia TG, Kochkarov VI, Artiushkova EB.

Eksp Klin Farmakol. 2008 Mar-Apr;71(2):29-31. Russian.

PMID:
18488903
14.

Effect of antioxidants pQ510 and resveratrol on regulatory function of the endothelium in rats with modeled arterial hypertension.

Gumanova NG, Artyushkova EB, Metel'skaya VA, Kochkarov VI, Pokrovskaya TG, Danilenko LM, Korneev MM, Pokrovskii MV, Pashin EN.

Bull Exp Biol Med. 2007 Jun;143(6):678-81. English, Russian.

PMID:
18239799
15.

Prooxidant effects of nitrofurantoin.

Novikov OO, Pokrovskii MV, Konovalenko AB.

Bull Exp Biol Med. 2002 Aug;134(2):148-50.

PMID:
12459837
16.

[Prophylactic syrups for population of environmentally polluted areas].

Ivanova TN, Khlebnikov VI, Pokrovskiĭ MV, Zakharchenko GL.

Vopr Pitan. 1998;(1):31-4. Russian.

PMID:
9606865
17.

[A simple gauge of volumetric blood flow velocity].

Vovereĭdt VV, Pokrovskiĭ MV, Galenko-Iaroshevskiĭ PA.

Farmakol Toksikol. 1988 Nov-Dec;51(6):95-6. Russian.

PMID:
3234549
18.

[Complex formation of lithium hydroxybutyrate with ions of Na+, K+, Ba2+, Mg2+, and Ca2+].

Galenko-Iaroshevckiĭ PA, Budarin LI, Buikliskiĭ VD, Grebennikov VN, Pokrovskiĭ MV.

Farmakol Toksikol. 1987 Nov-Dec;50(6):51-5. Russian.

PMID:
3436425
19.

[General principles of heart rate control during burst stimulation of the vagus nerve in various animals].

Sheĭkh-Zade IuR, Kruchinin VM, Sukach LI, Pokrovskiĭ MV, Urmancheva TG.

Fiziol Zh SSSR Im I M Sechenova. 1987 Oct;73(10):1325-30. Russian.

PMID:
3501381
20.

[Cardiotropic properties of lithium oxybutyrate in an experiment and in the clinic].

Galenko-Iaroshevskiĭ PA, Pokrovskiĭ MV, Skibitskiĭ VV.

Farmakol Toksikol. 1986 Sep-Oct;49(5):63-7. Russian.

PMID:
2429864

Supplemental Content

Loading ...
Support Center